Plasmalogene

Plasmalogen is a class of glycerophospholipids characterized by a vinyl-ether linkage at the first carbon (sn-1) of the glycerol backbone, with a fatty acyl group at the sn-2 position. The vinyl-ether bond yields 1-alkenyl-2-acyl phospholipids and is most commonly found in two headgroup varieties: plasmenylethanolamines (PlsEtn) and plasmenylcholine (PlsCho). This vinyl-ether bond distinguishes plasmalogens from diacyl phospholipids and contributes to unique physicochemical and antioxidant properties.

Distribution and concentration vary by tissue, but plasmalogens are particularly abundant in the heart, brain, and immune cells. They are enriched in myelin and synaptic membranes, where they help modulate membrane properties and signaling. Plasma plasmalogens also reflect broader peroxisomal lipid metabolism status.

Biosynthesis occurs mainly in peroxisomes, with initial steps catalyzed by enzymes such as dihydroxyacetone phosphate acyltransferase (DHAPAT) and alkylglycerone phosphate synthase (AGPS), which establish the ether bond. The molecule is then remodeled in the endoplasmic reticulum to yield the mature plasmalogen (typically PlsEtn or PlsCho). Peroxisomal dysfunction reduces plasmalogen levels, and genetic defects in peroxisome biogenesis or ether lipid synthesis—examples include Rhizomelic chondrodysplasia punctata (RCDP)—cause reduced plasmalogens and clinical features of peroxisomal disorders.

Functions attributed to plasmalogens include contributions to membrane structure and fluidity, reservoirs for polyunsaturated fatty acids, and antioxidant protection through scavenging of reactive oxygen species. They may also participate in lipid signaling and membrane trafficking.

Clinical relevance: low plasmalogen levels are observed in certain peroxisomal diseases and have been reported in aging and some neurodegenerative conditions, prompting interest in plasmalogen-based diagnostics and therapeutic approaches.